These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 10596359)

  • 1. Formulation development of allopurinol suppositories and injectables.
    Lee DK; Wang DP
    Drug Dev Ind Pharm; 1999 Nov; 25(11):1205-8. PubMed ID: 10596359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improvement of availability of allopurinol from pharmaceutical dosage forms I - suppositories.
    Samy EM; Hassan MA; Tous SS; Rhodes CT
    Eur J Pharm Biopharm; 2000 Mar; 49(2):119-27. PubMed ID: 10704894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioavailability of allopurinol oral and rectal dosage forms.
    Chang SL; Kramer WG; Feldman S; Ballentine R; Frankel LS
    Am J Hosp Pharm; 1981 Mar; 38(3):365-8. PubMed ID: 7223751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ketoprofen suppository dosage forms: in vitro release and in vivo absorption studies in rabbits.
    Babar A; Bellete T; Plakogiannis FM
    Drug Dev Ind Pharm; 1999 Feb; 25(2):241-5. PubMed ID: 10065359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salbutamol sulfate suppositories: influence of formulation on physical parameters and stability.
    Taha EI; Zaghloul AA; Kassem AA; Khan MA
    Pharm Dev Technol; 2003; 8(1):21-30. PubMed ID: 12665194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of additives on the physicochemical properties of liquid suppository bases.
    Choi H; Lee M; Kim M; Kim C
    Int J Pharm; 1999 Nov; 190(1):13-9. PubMed ID: 10528092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formulation effects on the mechanical and release properties of metronidazole suppositories.
    Adegboye TA; Itiola OA
    Afr J Med Med Sci; 2003 Sep; 32(3):247-51. PubMed ID: 15030082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medicament release from suppository bases I: Physicochemical characteristics and bioavailability of indomethacin in rabbits.
    Vidras NJ; Reid VE; Bohidar NR; Plakogiannis FM
    J Pharm Sci; 1982 Aug; 71(8):945-9. PubMed ID: 7120104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New Formulation and Evaluation of Camptothecin Encapsulated and/or Dispersed Suppository.
    Fatmi S; Taouzinet L; Lahiani-Skiba M; Skiba M; Iguer-Ouada M
    Anticancer Agents Med Chem; 2021; 21(9):1183-1190. PubMed ID: 32885761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allopurinol kinetics and bioavailability. Intravenous, oral and rectal administration.
    Appelbaum SJ; Mayersohn M; Dorr RT; Perrier D
    Cancer Chemother Pharmacol; 1982; 8(1):93-8. PubMed ID: 7094203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of various surfactants on the release of salbutamol from suppositories.
    Hanaee J; Javadzadeh Y; Taftachi S; Farid D; Nokhodchi A
    Farmaco; 2004 Nov; 59(11):903-6. PubMed ID: 15544795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and Stability Study of an Omeprazole Suppository for Infants.
    Bestebreurtje P; Roeleveld N; Knibbe CAJ; van Sorge AA; Plötz FB; de Wildt SN
    Eur J Drug Metab Pharmacokinet; 2020 Oct; 45(5):627-633. PubMed ID: 32594306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The dynamics of the drug release from suppositories. Part 5: Liberation of chlorpromazine from suppository bases (author's transl)].
    Pasich J; Drobnicka B; Kasprzyk A
    Pharmazie; 1981; 36(1):20. PubMed ID: 7220580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The dynamics of drug release from suppositories. Part 6: The effects of lipophil and hydrophilic suppository bases on the release of adeiphenin (author's transl)].
    Pasich J; Brobnicka B; Kasprzyk A
    Pharmazie; 1980; 35(7):416-7. PubMed ID: 6106209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and evaluation of immediate release diclofenac sodium suppositories.
    Sultan T; Hamid S; Hassan S; Hussain K; Ahmed A; Bashir L; Naz S; Maqbool T
    Pak J Pharm Sci; 2018 Sep; 31(5):1791-1795. PubMed ID: 30150172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preformulation studies for an ultrashort-acting neuromuscular blocking agent GW280430A. I. Buffer and cosolvent effects on the solution stability.
    Zhu H; Meserve K; Floyd A
    Drug Dev Ind Pharm; 2002; 28(2):135-42. PubMed ID: 11926357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of temperature on drug release and drug absorption in mixed type diclofenac sodium suppositories].
    Iwata M; Takayama K; Takahashi Y; Obata Y; Machida Y; Nagai T; Shirotake S
    Yakugaku Zasshi; 1999 Feb; 119(2):170-7. PubMed ID: 10067431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmaceutical studies of levothyroxine sodium hydrate suppository provided as a hospital preparation.
    Hamada Y; Masuda K; Okubo M; Nakasa H; Sekine Y; Ishii I
    Biol Pharm Bull; 2015; 38(4):625-8. PubMed ID: 25832643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of absorption enhancers in chloroquine suppository formulations: I. In vitro release characteristics.
    Onyeji CO; Adebayo AS; Babalola CP
    Eur J Pharm Sci; 1999 Dec; 9(2):131-6. PubMed ID: 10620725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Degradation kinetics of metronidazole in solution.
    Wang DP; Yeh MK
    J Pharm Sci; 1993 Jan; 82(1):95-8. PubMed ID: 8429500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.